Cross-Reactivity of Pantoprazole with Three Commercial Cannabinoids Immunoassays in Urine.

@article{Gomila2017CrossReactivityOP,
  title={Cross-Reactivity of Pantoprazole with Three Commercial Cannabinoids Immunoassays in Urine.},
  author={I. Gomila and B. Barcel{\'o} and A. Rosell and Sonia Avella and Laura Sahuquillo and M. Dastis},
  journal={Journal of analytical toxicology},
  year={2017},
  volume={41 9},
  pages={
          760-764
        }
}
Pantoprazole is a frequently prescribed proton pump inhibitor (PPI) commonly utilized in the management of gastrointestinal symptoms. Few substances have proved to cause a false-positive cannabinoid urine screen. However, a case of false-positive urine cannabinoid screen in a patient who received a pantoprazole dose has been recently published. The purpose of this study was to determine the potential cross-reactivity of pantoprazole in the cannabinoid immunoassays: Alere Triage® TOX Drug Screen… Expand
An assessment of urine THC immunoassay in healthy volunteers receiving an oral proton-pump inhibitor
TLDR
The results demonstrate that oral PPIs did not cause a false-positive THC using the THC One Step Marijuana Test Strip®, and large-scale research using other commercial urine immunoassays is warranted. Expand
Detectability of Dissociative Psychoactive Substances in Urine by Five Commercial Phencyclidine Immunoassays.
TLDR
The cross-reactivity study was performed in five different PCP IAs using urine-free, spiked samples and urine samples obtained from two 3-MeO-PCP overdose cases, and it was found that urine samples from the two overdose cases were positive for PCP in all IAs evaluated. Expand
Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants
TLDR
This study tried to identify maternal profiles that help to identify newborns exposed to psychoactive drugs during pregnancy by measuring biomarkers in neonatal matrices to develop several risk-based drug screening approaches to improve the early detection of exposed neonates. Expand
Other Common Uses for Urine Screening in Clinical Practice: Substance Use Disorders, Antipsychotic Adherence, Sexually Transmitted Infections
TLDR
Urine testing is routinely used for screening purposes in clinical practice, including urine screens for substance use disorders, to confirm antipsychotic medication adherence and to identify sexually transmitted infections in at risk populations. Expand
Ontogeny of Drug-Metabolizing Enzymes.
TLDR
This chapter summarizes data on the ontogeny of major human metabolizing enzymes involved in oxidation, reduction, hydrolysis, and conjugation of drugs, and the application in physiologically based pharmacokinetic model and regulatory submission are discussed. Expand
Características clínicas y factores de riesgo asociados a la exposición prenatal a drogas de abuso
Resumen Introduccion La identificacion temprana de los neonatos expuestos a drogas de abuso permite realizar un manejo clinico mas preciso. Objetivos Describir las caracteristicas clinicas eExpand
O-Difluorodeuteromethylation of phenols using difluorocarbene precursors and deuterium oxide.
The first O-difluorodeuteromethylation of phenols using commercial diethyl bromodifluoromethylphosphonate and deuterium oxide to prepare various difluorodeuteromethyl aryl ethers is reported. ThisExpand
Assessing the Reliability of Commercially Available Point of Care in Various Clinical Fields
TLDR
Key features of commercially available point of care (POC) devices, such as time to provide results, accuracy and imprecision, in several medical and veterinary fields are discussed. Expand
...
1
2
...

References

SHOWING 1-10 OF 16 REFERENCES
False-positive interferences of common urine drug screen immunoassays: a review.
TLDR
False-positive results support the generally accepted practice that immunoassay positive results are considered presumptive until confirmed by a second independent chemical technique. Expand
Investigation of interference by nonsteroidal anti-inflammatory drugs in urine tests for abused drugs.
TLDR
The small likelihood of a false-positive immunoassay test result for cannabinoids, benzodiazepines, or barbiturates after the acute or chronic ingestion of ibuprofen, or after the Chronic ingestion of naproxyn or fenoprofen is demonstrated. Expand
Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine.
TLDR
KIMS is more prone to cross-reactions by niflumic acid compared to EMIT, therefore, all positive screening tests for cannabinoids obtained by KIMS should be confirmed by another technique. Expand
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.
OBJECTIVES The results of newborn drug screening have far-reaching impact not only in healthcare, but also in the legal domain. Therefore, the accuracy of these results cannot be undervalued. WhenExpand
Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine.
We observed that antiretroviral therapy with efavirenz (EFV) produces urine samples that screen positive for Δ9-tetrahydrocannabinol (THC) exposure, despite the absence ofExpand
Consumption and quantitation of delta9-tetrahydrocannabinol in commercially available hemp seed oil products.
TLDR
Testing performed by the laboratory found that the concentration of THC in hemp oil products has been reduced considerably since the publication of earlier studies, and all volunteers were below positive screen and confirmation cutoffs within 48 h after cessation of ingestion. Expand
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire
TLDR
A case of a false-positive urine cannabinoid screen in a patient with CVS who received a dose of intravenous pantoprazole is described, which is described as a first case of its kind in the medical literature. Expand
Pharmacokinetics of pantoprazole in man.
TLDR
Pantoprazole showed lack of cytochrome P450 interaction with concomitantly administered drugs in any of the studies conducted to date, and Lack of interaction was also demonstrated with a coadministered antacid. Expand
Pharmacokinetics of Proton Pump Inhibitors in Children
TLDR
Because a pharmacokinetic/pharmacodynamic relationship exists for PPIs, the significant interindividual variability in their disposition may partly explain the wide range of therapeutic doses used in children. Expand
Proton Pump Inhibitors in Pediatrics
TLDR
Prolonged treatment of pediatric patients with PPIs has not caused cancer or significant abnormalities and the effectiveness of PPIs relates to their structures, which must undergo acidic activation within the parietal cell to allow the PPI to be ionized and form covalent disulfide bonds with cysteine bonds. Expand
...
1
2
...